Miromatrix Medical Inc., a life sciences company, develops a novel technology for bioengineering fully transplantable organs. Its proprietary technology is a platform that uses a two-step method of decellularization and recellularization designed to remove the porcine cells from the organs obtained from pigs and replace them with unmodified human cells. The company has collaborations with The Mayo Clinic, Mount Sinai Hospital, and The Texas Heart Institute. The company was formerly known as TayTech, Inc. Miromatrix Medical Inc. was incorporated in 2009 and is headquartered in Eden Prairie, Minnesota.

Filer	Shares	Latest Filing Date	Previously owned	Change	Share-Type	Market Value
Mayo Clinic	191.62K	2023-08-09	191.62K	0	Shares	335.91K
Legacy Wealth Asset Managem...	51.70K	2023-08-04	50.54K	1.16K	Shares	90.47K

NASDAQ:MIRO

Miromatrix Medical Inc.

Last Close

3.37

12/12 21:00

Market Cap

92.95M

Beta: -

Volume Today

631.56K

Avg: 57.52K

PE Ratio

−3.41

PFCF: −3.79

Institutional trades

Institutional Ownership

Current holdings institutionals